Planned intervention: On Wednesday April 3rd 05:30 UTC Zenodo will be unavailable for up to 2-10 minutes to perform a storage cluster upgrade.
Published August 14, 2019 | Version v1
Journal article Open

Regulation of cAMP accumulation and activity by distinct phosphodiesterase subtypes in INS-1 cells and human pancreatic beta-cells

  • 1. Department of Medicinal Chemistry and Molecular Pharmacology, Purdue University
  • 2. Deparment of Medicinal Chemistry and Molecular Pharmacology, Purdue University

Description

Pancreatic β-cells express multiple phosphodiesterase (PDE) subtypes, but the specific roles for each in β-cell function, particularly in humans, is not clear.  We evaluated the cellular role of PDE1, PDE3, and PDE4 activity in the rat insulinoma cell line INS-1 and in primary human β-cells using subtype-selective PDE inhibitors. Using a genetically encoded, FRET-based cAMP sensor, we found that the PDE1 inhibitor 8MM-IBMX, elevated cAMP levels in the absence of glucose to a greater extent than either the PDE3 inhibitor cilostamide or the PDE4 inhibitor rolipram.  In 18 mM glucose, PDE1 inhibition elevated cAMP levels to a greater extent than PDE3 inhibition in INS-1 cells, while PDE4 inhibition was without effect.  Inhibition of PDE1 or PDE4, but not PDE3, potentiated glucose-stimulated insulin secretion in INS-1 cells.  PDE1 inhibition, but not PDE3 or PDE4 inhibition, reduced palmitate-induced caspase-3/7 activation, and enhanced CREB phosphorylation in INS-1 cells.   In human β-cells, only PDE3 or PDE4 inhibition increased cAMP levels in 1.7 mM glucose, but PDE1, PDE3, or PDE4 inhibition potentiated cAMP levels in 16.7 mM glucose.  Inhibition of PDE1 or PDE4 increased cAMP levels to a greater extent in 16.7 mM glucose than in 1.7 mM glucose in human β-cells.  In contrast, elevation of cAMP levels by PDE3 inhibition was not different at these glucose concentrations.  PDE1 inhibition also potentiated insulin secretion from human islets, suggesting that the role of PDE1 may be conserved between INS-1 cells and human pancreatic β-cells.  Our results suggest that inhibition of PDE1 may be a useful strategy to potentiate glucose-stimulated insulin secretion, and to protect β-cells from the toxic effects of excess fatty acids.

Files

Pratt et al., Figure 1 Revised.tif

Files (26.1 MB)

Name Size Download all
md5:4d017f2f79701954a91c0821f7661b28
73.8 kB Download
md5:057bac888d32af4a53d79ada81c5aa89
81.7 kB Download
md5:af9ae1107b9f379d7f504ce4b2381ce8
10.6 kB Download
md5:b30b1c01b7a8ba1c9eabcd7a6cacb4af
74.0 kB Download
md5:75460e73e047a0ada79515f39ba4f6e6
71.5 kB Download
md5:f6e920f27ff58c80aea329f17d405fe7
34.6 kB Download
md5:036dca0aa11b7bb61853ff70ef2eaa8a
42.7 kB Download
md5:ec189cafb7ce8d56b3b99fe5ab70e80c
11.3 kB Download
md5:f3db716d07489fa9cc4866cd8925c9f2
9.7 kB Download
md5:056fd6f8a5447257383410faec49295d
11.5 kB Download
md5:38ff3d1f399fd0efc3db3daf24fe41f3
26.3 kB Download
md5:dfa3ee88f895f0907ed33e11a6394aab
308.1 kB Download
md5:00736c0aaa6bd38db76ba22a084caa23
2.5 MB Preview Download
md5:060bdc351a7b8e4401aef8b711c0037c
2.6 MB Preview Download
md5:6ebac79b485a24015af8ee4429e7bcf6
2.7 MB Preview Download
md5:6de313d997d56858be077c9e3459b2b8
2.1 MB Preview Download
md5:ca2e210280d1f27d490bd172d4b8f750
3.0 MB Preview Download
md5:11928fe90b51fa45d775131983c250f3
2.6 MB Download
md5:f899700a39d1fbe41983d362ab2b69db
675.1 kB Download
md5:bd1f3a4c9ccd289b81a4b176994289d3
2.8 MB Download
md5:28dbf5d9b71e8ce9a2572e600a1f2020
254.7 kB Download
md5:cea97dfabf367c23a8e57e232674411e
64.8 kB Download
md5:9e33df56316da16f39a889b75627271c
90.7 kB Download
md5:fc86357c3266b060dcbedfe83cd75e05
90.4 kB Download
md5:c36a78f1d0603fe819a5bebd56e62cda
13.6 kB Download
md5:73da86f9a966e2c3ffe53cb79ae6f6fb
1.9 MB Preview Download
md5:77f5887a6cb6d221aff4bc9c3ee217c1
2.8 MB Preview Download
md5:f87dc8b0268f228140ae9bf288af49ab
1.0 MB Preview Download